Trade OVID stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Ovid Therapeutics Inc. (OVID) is trading at US$2.72, up 1.26% today as of Sep 21, 09:51 EDT. The company has a market capitalisation of US$546.83M. Over the past 52 weeks, OVID has traded between US$1.18 and US$3.11. On Syfe you can trade OVID with $0 commission and add it to your watchlist.
| Previous close | US$2.69 |
|---|---|
| Market cap | US$546.83M |
| 52-week range | US$1.18 – US$3.11 |
| Volume | 5.9M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Ovid Therapeutics Inc.
Ovid Therapeutics, Inc. is a biopharmaceutical company dedicated to pioneering better, gentler medicines for the brain. It discovers and develops differentiated, small molecule medicines for neurological and neuropsychiatric disorders with significant unmet need. The company was founded by Matthew During and Jeremy M. Levin on April 1, 2014 and is headquartered in New York, NY.
Year: 2017
Oppenheimer Adjusts Ovid Therapeutics Price Target to $9 From $7, Maintains Outperform Rating
Aug 3, 12:54 PM · MT Newswires
Ovid Therapeutics Names Kevin Norrett Chief Business Officer, Promotes CFO and Chief Strategy Officer
Jul 8, 11:52 AM · MT Newswires
Ovid Therapeutics Inc. (OVID) stock is trading at US$2.72, +1.26% from the previous close of US$2.69.
The market cap for Ovid Therapeutics Inc. (OVID) stock is approximately US$546.83M.
The 52-week high for Ovid Therapeutics Inc. (OVID) stock is US$3.11.
The 52-week low for Ovid Therapeutics Inc. (OVID) stock is US$1.18.
Ovid Therapeutics Inc. (OVID) does not currently pay a dividend.
Stay on top of OVID
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
